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Anaerobic potentiometric titrations of b cytochromes have been carried out in beef heart submitochondrial 
particles in the presence of several specific inhibitors of electron transfer through the b-cl-site of the 
respiratory chain. Whereas antimycin show; no significant effect on the titration curve of cytochrome 
b-562, NoHOQnO is found to shift the E,,, of b-562 by 20-30 mV to the positive. Funiculosin raises the 
E,,, of b-562 by > 100 mV and also appears to bring about a minor shift of b-566 midpoint potential. In 
the presence of myxothiazol, both b cytochromes titrate with E,,, values 15-30 mV more positive than in 
the control. 
Respiratory chain Cytochrome b Redox titration 2-Alkyl-4-hydroxyquinoline N-oxide 
Funiculosin 
1. INTRODUCTION 
Under certain conditions antimycin can greatly 
increase the reducibility of mitochondrial 
cytochromes b-566 and b-562 by succinate and 
some other electron donors [ 1,2]. The mechanism 
of this effect had been studied in considerable 
detail. It was first proposed that the midpoint 
potentials of b cytochromes are raised by the 
action of the inhibitor [l], but subsequent 
experiments showed that the reducing effect of 
antimycin is absolutely depend&t on the presence 
of an oxidant, such as 02 or ferricyanide, and is 
accounted for by a purely kinetic mechanism 
(reviewed [3]). In particular, anaerobic redox titra- 
tions did not reveal any positive shift of E,,, of 
either cytochrome b-566 or b-562 in the presence of 
antimycin [4,5]. 
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Abbreviations: HpHOQnO, 2-n-heptyl-4-hydroxy- 
quinoline N-oxide; NoHOQnO, 2-n-nonyl-4-hydroxy- 
quinoline N-oxide; SMP, submitochondrial particles 
Myxothiazol 
A number of other b-cl-site specific inhibitors 
including HpOHQnO [6,7], funiculosin [8], diuron 
P,lOl, mucidin [g-11] and myxothiazol (in 
preparation) have been observed to bring about 
‘extra-reduction’ of a variable size of one or both 
mitochondrial b cytochromes. However, in neither 
case had the mechanism of the effect been 
scrutinized to the same extent as with antimycin. 
According to [7], the additional reduction of 
cytochromes b observed in the presence of HpHO- 
QnO is fully analogous to the extra-reduction in- 
duced by antimycin. However, we have found that 
NoHOQnO can stimulate the reduction of 
cytochrome b-562 in submitochondrial particles 
under the conditions in which antimycin does not 
exert such an effect; e.g., in the presence of ascor- 
bate and redox mediators such as N,N,N ‘,N ‘- 
tetramethyl-p-phenylenediamine, dichlorophenol- 
indophenol, phenazine methosulfate [12]. A 
similar difference between the effects of 
funiculosin and antimycin was noticed in [8]. 
Here, NoHOQnO, funiculosin and myxothia- 
zol, in contrast to antimycin, increased reducibility 
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of cytochromes b under the conditions of anaero- 
bic potentiometric titration. 
2. METHODS 
Antimycin and NoHOQnO were purchased 
from Serva. Funiculosin was a generous gift from 
Dr P. Bollinger (Sandoz, Basel) obtained through 
the courtesy of Professor P. Walter (University of 
Basel). Myxothiazol was kindly donated by Dr W. 
Trowitzsch (Gesellschaft fur Biotechnologische 
Forschung, Braunschweig). Ru~H3)~Cl~ was 
from Alfa Products (Denver CO) and 1,6naph- 
thoquinone-2-sulfonate was from Eastman- 
Kodak. Other reagents were commercial products 
mainly from Sigma, Serva and Fluka of the purest 
grade available. 
Beef heart SMP were prepared according to [13] 
with minor modifications. Anaerobic poten- 
tiometric titrations were carried out as detailed in 
[14] in a magnetically stirred 1 cm standard spec- 
trophotometer cell in an Aminco DW 2+M spec- 
trophotometer. Redox potential was measured 
with a platinum wire electrode vs a calomel semi- 
micro reference electrode (K 141, Radiometer) fed 
into an MV-870 digital pH/mV meter (DDR) with 
a readability of 0.1 mV. The electrode system was 
calibrated with a ferricyanide/ferrocyanide buffer 
as in [15]. Argon, purified by passing through an 
alkaline pyrogallol solution, was flushed con- 
tinuously over the reaction mixture during the 
titrations. In each titration, stepwise reduction of 
b cytochromes was first carried out by small addi- 
tions of freshly prepared ascorbate, NADH and 
dithionite solutions and, after the completion of 
the reduction, oxidative titration by ferricyanide 
was performed. The detailed titrations were car- 
ried out at a fixed wavelength pair (562 nm minus 
575 nm), but in control experiments pectra were 
also scanned at various characteristic Eh values, 
allowing the mixture to equilibrate for 3-5 min at 
each redox potential. 
Curve fitting was performed in a Nova 3D com- 
puter using a program developed by Dr Alexander 
L. Drachev in this laboratory. 
3. RESULTS 
Fig.1 compares the effects of NoHOQnO and 
antimycin on the high-potential half of b 
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Pig. 1. NoHOQnO-induced shift of cytochrome b-562 
midpoint potential. Beef heart SMP (1 mg protein/ml) 
in the medium containing 0.29 M sucrose, 20 mM 
morpholinopropane sulfonate (pH 6.8), 0.5 mM EDTA 
and, where indicated, 1.5 pM antimycin or 6.5 PM 
NoHOQnO. Redox mediators: 100 /IM of each diamino- 
durol, phenazine methosulfate and duroquinone, 50 pM 
1,4-naphthoquinone-2-sulfonate; (m, A) 100 pM phena- 
zine ethosulfate. Theoretical Nernst curves for 2 one- 
electron components are drawn through the points with 
E,,, values: (1) +45 mV and - 25 mV; (2) + 75 mV and 
-40 mV; the contributions of the high- and low- 
potential components to AA;;::;& are 0.6 and 0.4, 
respectively. In this experiment cytochrome b-566 was 
not titrated in detail in the NoHOQnO- or antimycin- 
inhibited SMP; therefore, the characteristics of the low- 
potential component of curve 2 are rather approximate 
and have been concerned solely to allow for simulation 
of the complete titration curve. The 100% reduction 
level was measured in each case upon addition of a small 
excess of dithionite. 
cytochrome potentiometric titration curve, known 
to belong to cytochrome b-562 [2-51. (The low- 
potential part of the curve was not assayed in detail 
in the antimycin- or NoHOQnO-inhibited SMP in 
this experiment.) It can be seen that in the presence 
of NoHOQnO (curve 2), the high-potential 
cytochrome b titrates at Eh values -30 mV more 
positive compared to the control (curve 1). 
Control spectra recordings showed clearly, in 
agreement with ]12], that it was increased reduc- 
tion of cytochrome b-562 brought about by 
NoHOQnO under anaerobic conditions over Eh 
O-120 mV (not shown). At lower redox potentials, 
a small spectral shift of b-562 f16] was the only ef- 
fect of NoHOQnO resolved by the difference spec- 
tra; no increased reduction of b-566 could be 
detected (not shown, [12]). 
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In contrast to NoHOQnO, antimycin exerts no 
significant effect on the redox titration of b 
cytochromes in the high-potential region (see (0) 
and ( n ) in curve 1 of fig. l), which corroborates the 
data in [4] (but see [S]). Accordingly, antimycin 
has been found to reverse the additional reduction 
of cytochrome b-562 induced by NoHOQnO under 
anaerobic conditions [ 121. 
The effect of funiculosin on the potentiometric 
titration curve of b cytochromes has been found to 
be more dramatic than that of NoHOQnO (fig.2). 
One can see that, in the presence of this antibiotic 
the high-potential cytochrome b, identified as 
b-562 by appropriate spectral recordings (not 
shown), titrates at EI, - 120 mV more positive com- 
pared to the control. There seems to be also a 
minor shift to the positive of the low-potential 
component of the titration curve (cytochrome 
b-566). 
0 conlml 
. +myxothiorol 
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Fig.2. Effects of funiculosin and myxothiazol on the 
redox titration of cytochromes b. Beef heart SMP 
(0.8 mg protein/ml) in the medium containing 0.3 M 
sucrose, 20 mM N-2_hydroxyethylpiperazine- 
N’-Zethane sulfonate (pH 7.7), 5 mM MgS04 and, 
where indicated, myxothiazol(l.2 pg/ml) or funiculosin 
(2pg/ml); T = 30°C. Redox mediators: 50pM diami- 
nodurene, 50 PM 1,4-naphthoquinone-2-sulfonate, 
40 ,uM Ru(NH&Cl~, 25 pM phenazine methosulfate, 
25 /IM phenazine ethosulfate, 50 pM duroquinone and 
50 pM menadione. The two-component Nernst curves 
drawn through the points assume the following Em 
values for the high- and low-potential cytochromes: (1) 
+ 10 mV and - 100 mV; (2) + 35 mV and - 85 mV; (3) 
+ 130 mV and - 80 mV. The contributions of the high- 
and low-potential components to AA;$:y,5 are 0.55 and 
0.45, respectively. 
In fig.2, redox titration of b cytochromes in the 
presence of myxothiazol is shown. It can be seen 
that the inhibitor brings about a slight but discerni- 
ble dislocation of the entire titration curve to 
higher Eh values, which can be accounted for by 
the positive shifts of E,,, of b-566 and b-562 by 
-20 mV. 
4. DISCUSSION 
These results indicate that the increased 
reducibility of b cytochromes induced by NoHO- 
QnO [6,7,12] and funiculosin [8] may in fact com- 
prise two different effects. 
(1) In the presence of succinate these inhibitors 
are likely to bring about the oxidant-dependent 
extra-reduction of both cytochromes b-566 and 
b-562 [6,8,12] similarly to antimycin [2,3]. This 
non-equilibrium effect will be consistent with 
NoHOQnO and funiculosin inhibiting the electron 
flow at the same site as antimycin [7,8,17]; i.e., 
between b cytochromes and ubiquinone in centre i 
of the Q cycle [ 181. Accordingly, all 3 antibiotics 
stimulate Hz02 and Oi- generation in b-cl-site 
[19,20]. 
(2) NoHOQnO and funiculosin stimulate the 
reduction of cytochrome b-562 as a consequence of 
the positive shift of this haemoprotein midpoint 
potential; this effect accounts for the differences in 
redox behaviour of b cytochromes in the presence 
of antimycin, and NoHOQnO [12] or funiculosin 
PI. 
The preferential influence of funiculosin and 
NoHOQnO on Em of the high-potential of the two 
b cytochromes agrees well with the hypothesis that 
it is the reaction of b-562 with CoQ which is block- 
ed by centre i inhibitors [ 181. Accordingly, both in- 
hibitors perturb the optical absorption spectrum of 
cytochrome b-562 in yeast [9,20] and beef heart 
[16,22] mitochondrial respiratory chain. It may 
seem surprising that antimycin, which is con- 
sidered to be a typical centre i inhibitor [18] and is 
known to alter optical and EPR spectra of 
cytochrome b-562 [ 11, does not modulate the E,,, of 
this redox centre. Although in the presence of an- 
timycin the high-potential part of b-562 redox 
titration curve shifted to lower Eh [5], such an ef- 
fect has not been observed by others ([4]; this 
239 
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paper). However, the effect of antimycin on the Em 
of cytochromes b may depend critically on pH 
since this inhibitor was shown to modify the pro- 
tonic function (E,/pH-dependence) of b 
cytochromes [23,24]. 
In contrast to NoHOQnO and funiculosin, myx- 
othiazol [25,26] behaves as a typical centre o in- 
hibitor [27] and suppresses the antimycin-induced 
extra-reduction of b cytochromes (in preparation). 
Therefore, we were somewhat perplexed by an 
observation that myxothiazol itself brings about a 
small additional reduction of b-562 and b-566 in 
the KCN-inhibited succinate/fumarate-poised 
SMP. The finding that myxothiazol slightly raises 
the Em of both cytochromes b can resolve this 
discrepancy. The same explanation applies 
possibly to a very small additional reduction of 
cytochromes b-566 and b-562 induced by mucidin 
Vll. 
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